Who is sponsoring NCT05245864?

NCT05245864 is sponsored by University of Arkansas.

What drugs are being tested in NCT05245864?

Interventions in NCT05245864: blood flow restriction, physical therapy standard of care.

What condition does NCT05245864 study?

NCT05245864 studies Anterior Cruciate Ligament Injuries.

Is NCT05245864 still recruiting?

NCT05245864 is currently terminated. Last updated 9 October 2024.

Are results published for NCT05245864?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2024-10-09 · How we verify

NCT05245864

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Blood Flow Restriction Training in ACL Surgery

Terminated NA Results posted Last updated 9 October 2024

What this trial tests

NA trial testing blood flow restriction in Anterior Cruciate Ligament Injuries in 2 participants. Terminated before completion.

Timeline

18 April 2022

Primary endpoint
30 January 2023

30 January 2023

Quick facts

Lead sponsor	University of Arkansas
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	2
Start date	18 April 2022
Primary completion	30 January 2023
Estimated completion	30 January 2023
Sites	1 location across United States

Drugs / interventions tested

blood flow restriction
physical therapy standard of care

Conditions studied

Anterior Cruciate Ligament Injuries — all drugs for Anterior Cruciate Ligament Injuries →

Sponsor

University of Arkansas

Who can join

Adults 18 to 34, any sex, with Anterior Cruciate Ligament Injuries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This will be a randomized pilot study to determine the effectiveness of Personalized Blood Flow Restriction (PBFR) technique in conjunction with prescribed physical therapy (PT) in a cohort of anterior cruciate ligament (ACL) reconstruction subjects

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of blood flow restriction

Trials testing the same drug.

NCT07451210 — Evaluating the Efficacy of Blood Flow Restriction Therapy in a Randomized Clinical Trial for Postoperative Rehabilitatio · NA · recruiting
NCT07322250 — The Effect of Blood Flow Restriction Training on Postmenopausal Stress Urinary Incontinence · NA · not yet recruiting
NCT07130812 — Blood Flow Restriction Training as a Targeted Intervention for Rowers With Back Pain. · NA · recruiting
NCT07236554 — Blood Flow Restriction Training Versus Mulligan Technique in Treatment of Lateral Epicondylitis · NA · completed
NCT06739148 — The Enhancement Effect of Low-Level Laser Therapy for Muscle Training with Combined NMES and BFR · NA · recruiting

Other recruiting trials for Anterior Cruciate Ligament Injuries

Currently open trials in the same condition.

NCT07501013 — Clinical Outcomes of Arthroscopic Surgeries for Shoulder and Knee Sports Injuries · recruiting
NCT07333092 — Investigation of the Effects of Proprioceptive Exercises After Anterior Cruciate Ligament Surgery · NA · recruiting
NCT07346326 — Comparative Study of Functional Outcomes Between Peroneus Longus and Hamstring Tendon Autografts in Arthroscopic ACL Rec · NA · recruiting
NCT07306221 — Effect of Visual-Guided Balance Training on Knee Motor Function and Biomechanical Characteristics After ACL Reconstructi · NA · recruiting
NCT07486466 — ACL Mechanical Property Changes in Female Collegiate Basketball Players During a Competitive Season · active not recruiting

Other University of Arkansas trials

Trials by the same sponsor.

NCT07029776 — MMulti-Immune HR; Multi-Target Immunotherapy for High-Risk Multiple Myeloma · Phase 2 · not yet recruiting
NCT07341399 — Essential Amino Acid Supplementation in Adult Spinal Deformity Patients · NA · not yet recruiting
NCT07071766 — Improving Outcomes for Early Postpartum Mothers in Outpatient MOUD Treatment · NA · recruiting
NCT05823727 — Effects of Collagen Peptide Supplementation on Connective Tissue Remodeling, Functional Outcomes, and Wound Healing Afte · NA · recruiting
NCT06604065 — Essential Amino Acids and Parkinsons Disease · Phase 1 · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05245864 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Arkansas
Last refreshed: 9 October 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05245864.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing